tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Coherus Biosciences (CHRS) Similar Stocks

Compare
1,637 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Coherus Biosciences
$1.35
$172.85M
-16.15%
3 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$1.91
$286.31M
136.05%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protalix
$1.79
$147.17M
25.76
-0.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$18.52
$155.24M
27.90
-3.59%
2 Buy
0 Hold
0 Sell
Moderate Buy
Genfit SA
$5.42
$219.11M
56.73%
2 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma
$1.86
$180.57M
20.00%
3 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CHRS
Coherus Biosciences
1.35
-0.35
-20.59%
SLS
SELLAS Life Sciences Group
2.03
1.11
120.65%
PLX
Protalix
1.79
0.04
2.29%
MCRB
Seres Therapeutics
16.94
-0.86
-4.83%
GNFT
Genfit SA
5.99
2.19
57.63%
IPHA
Innate Pharma
1.86
-0.51
-21.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts